Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2004

Yemelyanova AV, Winter W, Seidman JD. Venous thrombosis in the broad ligament: is it a predictor of postoperative pulmonary embolism in gynecological cancer patients? A case-control study. Int J Gynecol Pathol. 2004;23(2):176-9.

Ross P, Magro CM, King MA. Endobronchial histoplasmosis: a masquerade of primary endobronchial neoplasia--a clinical study of four cases. Ann Thorac Surg. 2004;78(1):277-81.

Ito K, Chen J, Khodadadian JJ, Seshan SV, Eaton C, Zhao X, et al. Liposome-mediated transfer of nitric oxide synthase gene improves renal function in ureteral obstruction in rats. Kidney Int. 2004;66(4):1365-75.

Takahashi C, Contreras B, Bronson RT, Loda M, Ewen ME. Genetic interaction between Rb and K-ras in the control of differentiation and tumor suppression. Mol Cell Biol. 2004;24(23):10406-15.

He B, Chadburn A, Jou E, Schattner EJ, Knowles DM, Cerutti A. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J Immunol. 2004;172(5):3268-79.

Westblade LF, Ilag LL, Powell AK, Kolb A, Robinson CV, Busby SJ. Studies of the Escherichia coli Rsd-sigma70 complex. J Mol Biol. 2004;335(3):685-92.

Eron JJ, Gulick RM, Bartlett JA, Merigan T, Arduino R, J Kilby M, et al. Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV. J Infect Dis. 2004;189(6):1075-83.

Ramey CJ, Howar S, Adkins M, Linger J, Spicer J, Tyler JK. Activation of the DNA damage checkpoint in yeast lacking the histone chaperone anti-silencing function 1. Mol Cell Biol. 2004;24(23):10313-27.

Morales G, Linares JF, Beloso A, Albar JP, Martinez JL, Rojo F. The Pseudomonas putida Crc global regulator controls the expression of genes from several chromosomal catabolic pathways for aromatic compounds. J Bacteriol. 2004;186(5):1337-44.

Vonderheide RH, Domchek SM, Schultze JL, George DJ, Hoar KM, Chen D-, et al. Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes. Clin Cancer Res. 2004;10(3):828-39.